Product image of Hylaton (Chlortalidone) supplied by GNH India

Hylaton

Active Ingredient:
Chlortalidone
Origin:
EU

Hylaton (Chlortalidone)

Chlortalidone, the active ingredient in Hylaton, is a thiazide‑like diuretic presented as a tablet for oral use. It helps control high blood pressure and reduces fluid retention in conditions such as heart failure, renal disease, and liver cirrhosis.

GNH India supplies Hylaton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Morningside Healthcare Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hylaton, a thiazide‑like diuretic, is used to manage conditions involving excess fluid or elevated blood pressure.

  • Hypertension: lowers systolic and diastolic pressure to reduce cardiovascular risk.
  • Edema associated with heart failure: promotes fluid loss to relieve pulmonary and peripheral congestion.
  • Edema due to renal disease: enhances sodium and water excretion when kidney function is impaired.
  • Edema due to liver cirrhosis: reduces ascites and peripheral swelling by increasing urinary output.

How It Works

  • Chlortalidone inhibits sodium‑chloride reabsorption in the distal convoluted tubule of the nephron. By blocking the Na+/Cl‑ cotransporter, it increases urinary excretion of sodium and water, leading to a reduction in extracellular fluid volume and a decrease in peripheral vascular resistance, which together lower blood pressure and alleviate edema.

Side Effects

Adverse reactions may occur with chlortalidone therapy.

Common Side Effects

  • Increased urination: more frequent need to void.
  • Electrolyte imbalance (low potassium): may cause muscle weakness or cramps.
  • Dizziness or light‑headedness, especially on standing.
  • Headache: mild to moderate intensity.
  • Fatigue or general weakness.
  • Elevated blood glucose: may affect diabetic control.

Serious or Rare Side Effects

  • Severe dehydration or hypovolemia.
  • Hyponatremia or severe electrolyte disturbances.
  • Hyperuricemia or gout flare‑ups.
  • Allergic skin reactions such as rash or Stevens‑Johnson syndrome.
  • Pancreatitis: abdominal pain with elevated enzymes.
  • Blood dyscrasias including leukopenia or thrombocytopenia.

Precautions & Warnings

Before initiating chlortalidone, consider the following safety measures.

  • Monitor electrolytes: check serum potassium, sodium, and magnesium regularly.
  • Assess renal function: evaluate creatinine clearance and adjust use if impaired.
  • Evaluate blood pressure: ensure adequate control without excessive hypotension.
  • Use cautiously in diabetes: monitor blood glucose as hyperglycemia may worsen.
  • Avoid in severe hepatic impairment: risk of accumulation and toxicity.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Chlortalidone can affect the activity of several other medicines.

Major Interactions (Avoid)

  • Lithium: increased lithium levels may cause toxicity.
  • Cyclosporine: enhanced nephrotoxic risk.
  • High‑dose NSAIDs: may reduce diuretic efficacy and impair renal function.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: additive blood‑pressure lowering effect, monitor for hypotension.
  • Beta‑blockers: may enhance antihypertensive response.
  • Other diuretics: risk of excessive electrolyte loss.
  • Corticosteroids: may counteract diuretic effect and increase sodium retention.
  • Antidiabetic agents: monitor glucose as diuretic may raise blood sugar.

Frequently Asked Questions

Hylaton contains chlortalidone, a thiazide‑like diuretic indicated for managing hypertension and reducing fluid buildup (edema) associated with heart failure, chronic kidney disease, and liver cirrhosis. It helps lower blood pressure and promotes the excretion of excess sodium and water.

Chlortalidone blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of sodium, water, and potassium, which lowers blood volume and peripheral resistance, thereby decreasing blood pressure and edema.

The appropriate dose of Hylaton is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and renal function. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of chlortalidone in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Hylaton, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Chlortalidone is a thiazide‑like diuretic, offering a longer duration of action than many thiazide diuretics such as hydrochlorothiazide. It is often preferred for resistant hypertension or when a more potent natriuretic effect is needed, while having a similar safety profile to other agents in its class.

Store Hylaton at room temperature, below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Hylaton is taken orally, usually with a full glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal irritation. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include severe dehydration, electrolyte disturbances such as hyponatremia or hypokalemia, and rare but significant reactions like allergic skin eruptions, pancreatitis, or blood dyscrasias. Prompt medical attention is required if symptoms such as extreme weakness, rapid heartbeat, or severe rash develop.

Hylaton should be avoided in individuals with known hypersensitivity to chlortalidone or other sulfonamide drugs, severe renal impairment, anuria, or uncontrolled electrolyte abnormalities. Patients with severe liver disease should also use it only under close medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.